Home » Topics » BioWorld Science

BioWorld Science
RSS

Ascletis updates clinical trial in China with Ganovo and ritonavir for novel coronavirus pneumonia

Feb. 27, 2020

iTeos initiates phase I/II study of EOS-884448 in advanced cancers

Feb. 27, 2020

FDA approves Barhemsys for prevention and treatment of PONV

Feb. 27, 2020

MapKure initiates first-in-human study of BGB-3245 in advanced or refractory tumors

Feb. 27, 2020

Genentech and Roche divulge KRAS inhibitors

Feb. 27, 2020

Inflazome completes first-in-human study of NLRP3 inflammasome inhibitor somalix

Feb. 27, 2020

G1 Therapeutics identifies ER modulators

Feb. 27, 2020

Medshine Discovery discloses RET inhibitors

Feb. 27, 2020

Gilead Sciences patents IRAK-4 inhibitors

Feb. 27, 2020

ViiV Healthcare presents new antivirals for HIV infection

Feb. 27, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.